Loomis, Sayles & Company
BCRX icon

Loomis, Sayles & Company’s BioCryst Pharmaceuticals BCRX Stock Holding History

Loomis, Sayles & Company’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,356,216
Closed -$38.3M – 975
2022
Q1 		$38.3M Buy
2,356,216
+919,104
+64% +$14.9M 0.05% 178
2021
Q4 		$19.9M Buy
+1,437,112
New +$19.9M 0.02% 308